AN2 Therapeutics, Inc. (ANTX): Broker Consensus Forecast

AN2 Therapeutics, Inc. (ANTX) focuses on developing anti-infective agents while outsourcing production and testing to third-party contractors to minimize capital expenditures. The business possesses strong defensive qualities, as demand for lung therapy remains independent of market cycles. This chart on the GURU.Markets platform shows a consensus forecast of 9.01. However, the company's survival currently depends on the resumption of clinical trials amid extremely low cash reserves.

ANTX - AN2 Bio Consensus Target over the range 04/28/2023 - 11/14/2026

Analytical breakdowns for AN2 Therapeutics, Inc. (ANTX)

- stock value and consensus price forecast:

Stock Price an2therapeutics.com|ANTX - Price Target Chart

- stock exchange capitalization data:

Market Capitalization AN2 Bio|ANTX - Real Price to Acquire Entire Company

- business book valuation details:

Book Price of a Share AN2 Therapeutics|ANTX - Company Net Assets|Capitalization to Book Value Ratio an2therapeutics.com|ANTX - Aggregate Company Assets

- business debt structure and liquidity details:

Aggregate Debt to Equity AN2 Therapeutics, Inc.|ANTX - Long-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital an2therapeutics.com|ANTX - Company Aggregate Debts|Debts to Book Capitalization AN2 Bio|ANTX - Company Long-Term Debt|Company Short-Term Loans and Borrowings AN2 Therapeutics|Quick Liquidity Indicator an2therapeutics.com

- earnings and market ratios statistics:

ANTX - Net Profit|Projected Future Earnings AN2 Therapeutics, Inc.|ANTX - Price to Earnings Ratio|Future Price to Earnings Multiple an2therapeutics.com|ANTX - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio AN2 Bio|ANTX - Profit before payment of interest, taxes and amortization|Earnings per share for the last 12 months AN2 Therapeutics|ANTX - Net earnings per share (EPS TTM)|Year-over-year net earnings per share trend for the last twelve months an2therapeutics.com|ANTX - Earnings growth in current year|Expected net earnings per share growth next year AN2 Therapeutics, Inc.

- sales revenue and business income indicators:

ANTX - Revenue and Sales Volume|Company Future Sales Volume an2therapeutics.com|ANTX - Market Cap to Revenue|Price to Expected Revenue Ratio AN2 Bio

General company analysis:ANTX AN2 Therapeutics Inc

Flagship merchandise of AN2 Therapeutics

For AN2 Therapeutics, Inc. (ANTX), the consensus target price aggregates average fair value estimates from leading analysts, establishing a dynamic benchmark for the asset's fundamental attractiveness. This indicator reflects overall market confidence in the company's capitalization, which is currently being adjusted to account for risks of international clinical trial disruptions and logistical gaps in biomaterial supplies caused by geopolitical instability.

Competitors of AN2 Therapeutics, Inc.